SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 571 filers reported holding SEAGEN INC in Q1 2023. The put-call ratio across all filers is 2.46 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $211,128,359 | +49.4% | 995,182 | +35.5% | 0.02% | +50.0% |
| Q2 2023 | $141,342,219 | +2.0% | 734,395 | +7.3% | 0.01% | -6.7% |
| Q1 2023 | $138,545,568 | +48.1% | 684,276 | -6.0% | 0.02% | +36.4% |
| Q4 2022 | $93,574,813 | +9.1% | 728,152 | +16.2% | 0.01% | -8.3% |
| Q3 2022 | $85,750,000 | -16.0% | 626,675 | +8.7% | 0.01% | -7.7% |
| Q2 2022 | $102,039,000 | +81.2% | 576,692 | +47.5% | 0.01% | +62.5% |
| Q1 2022 | $56,314,000 | -21.8% | 390,937 | -16.1% | 0.01% | -11.1% |
| Q4 2021 | $72,004,000 | +20.5% | 465,747 | +32.3% | 0.01% | +12.5% |
| Q3 2021 | $59,776,000 | +30.8% | 352,038 | +21.6% | 0.01% | +33.3% |
| Q2 2021 | $45,711,000 | -28.3% | 289,527 | -36.9% | 0.01% | -33.3% |
| Q1 2021 | $63,726,000 | +5.4% | 458,914 | +32.9% | 0.01% | 0.0% |
| Q4 2020 | $60,454,000 | – | 345,181 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |